BP (BP) Q4 2025 earnings review
Buybacks Suspended as 'Green' Impairments Crush Earnings
BP delivered a shock to the thesis in Q4: despite solid operating cash flow ($7.6B) and an Underlying Replacement Cost (RC) profit beat ($1.54B vs $1.17B last year), the Board suspended share buybacks immediately. The goal is to force Net Debt down to the $14-18B range (currently $22.2B). The reported numbers were ugly: a $3.4B loss attributable to shareholders, driven by $3.9B in adjusting items, primarily impairments in the 'transition' businesses (offshore wind, biofuels). Management is pivoting to a 'back to basics' financial frame: selling Castrol for cash, cutting Capex, and prioritizing the balance sheet over capital returns.
🐂 Bull Case
Despite the noise, the engine is running. Operating Cash Flow was $7.6B in Q4, actually up slightly from Q3 ($7.4B) and flat vs prior year. This fully covers the dividend and Capex, suggesting the liquidity crisis is strategic, not operational.
Management raised the structural cost reduction target to $5.5-6.5B by 2027. The Castrol sale (65% stake) is expected to bring ~$6B cash in 2026, which accelerates the deleveraging timeline significantly.
🐻 Bear Case
The removal of the buyback 'floor' changes the equity story overnight. Management retired the guidance of returning 30-40% of surplus cash. Investors are now paid only via dividends while waiting for debt targets to be hit.
The $4.6B pre-tax impairment charge (primarily in Gas & Low Carbon) confirms that previous investments in wind and biofuels were overvalued. BP is effectively writing off years of 'green' strategy execution errors.
⚖️ Verdict: 🔴
Bearish. While the balance sheet prioritization is prudent long-term, the sudden suspension of buybacks and the magnitude of asset write-downs ($4.6B) signal that the transition strategy has burned significant capital. The stock is now a 'show me' story on debt reduction.
Key Themes
Shareholder Returns: The Buyback Is Dead (For Now)
Reversing. BP explicitly 'retired' its guidance to return 30-40% of surplus cash to shareholders. Buybacks are suspended until credit metrics improve. While the dividend was raised 4% to 8.32 cents/share, the total cash return yield has collapsed. Management is prioritizing the $14-18B Net Debt target over equity support.
Massive Impairments in Low Carbon
A $3.6B post-tax adverse impact from adjusting items in Gas & Low Carbon Energy reveals deep issues in the portfolio. Specific mentions include Lightsource BP (solar) and Archaea (biogas). This suggests BP overpaid or mismanaged these assets during the peak 'ESG' hype cycle.
Divestment Super-Cycle: Selling Castrol
BP is shrinking to grow value. The agreement to sell 65% of Castrol (valued at $10.1B enterprise value) and the exit from US onshore wind mark a pivot to a simpler structure. 2026 divestment proceeds are guided to $9-10B—this is the primary lever to fix the balance sheet.
Upstream Production Plateau
Stable. 2026 guidance calls for upstream production to be 'slightly lower' or 'broadly flat'. With Oil Production & Operations profit dropping to $1.96B (from $2.9B a year ago) due to lower realizations, BP needs volume growth to offset price weakness, but isn't getting it.
Customers & Products: The Stability Anchor
Accelerating relative to group. While Upstream profits fell, Customers & Products delivered $1.35B in underlying profit (vs a $302M loss in 24Q4). Convenience and mobility were strong, and refining benefited from lower turnaround activity. This segment is effectively subsidizing the rest of the business right now.
Macro Headwind: Lower Realizations
The macro environment is deteriorating. BP realized $61.06/bbl for liquids in 25Q4 vs $70.41/bbl in 24Q4 (-13%). Gas realizations fell from $5.85 to $5.21/mcf. The updated impairment assumptions lower long-term Brent forecasts to $60/bbl by 2050, signaling management expects lower-for-longer pricing.
Other KPIs
Accelerating vs Q4'24 ($1.17B) but the mix is concerning. The beat was driven by tax variations and the Customers segment, while core Oil & Gas profits were pressured by price. Full year profit dropped to $7.5B from $8.9B in 2024.
Stable. Down slightly from $23.0B a year ago, but sticky. The target is $14-18B. Management has realized they cannot hit this target purely through organic cash flow while paying dividends and buybacks, hence the strategic shift.
Stable. A bright spot. Up from $7.4B in 24Q4. This demonstrates that the asset base is generating cash, even if accounting profits are hit by impairments. However, working capital build in FY25 consumed cash vs a release in FY24.
Guidance
Stable. Oil production & operations expected flat; Gas & low carbon energy expected lower. This implies no volume leverage to offset potential price declines.
Decelerating. Down from $14.5B in 2025 and $16.2B in 2024. This confirms the 'financial discipline' mode. The spend is weighted to the first half.
Accelerating massively. Up from $5.3B in 2025. This includes ~$6B from the Castrol transaction. This line item is the single most important factor for the balance sheet restoration plan.
Stable. A continuing drag on cash flow, largely weighted to Q2 ($1.1B). This legacy cost continues to eat into free cash flow over a decade after the incident.
Key Questions
Buyback Reinstatement Triggers
You suspended buybacks to reach the $14-18B net debt target. Once achieved (likely late 2026 via Castrol proceeds), is the automatic reinstatement of buybacks guaranteed, or will the capital allocation framework be revisited again?
Impairment Visibility
After a $4.6B write-down in Q4 focused on transition assets (Lightsource, Archaea), how confident are you that the carrying value of the remaining Low Carbon portfolio is accurate? Are further write-downs likely?
Upstream Decline Mitigation
With Gas & Low Carbon production guided lower for 2026 and Oil flat, where is the medium-term volume growth coming from to offset natural decline, especially given the reduced Capex budget?